ACDS
510(k) K120005
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK120005 | Date29 Mar 2012 | StatusActive |
Official records
- FDA 510(k) database K120005
From the FDA record
- Received by the FDA
- 3 Jan 2012
- FDA decision
- 29 Mar 2012 (Substantially Equivalent)
- FDA review time
- 86 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Recalls
-
- Terminated Z-1739-2022
Acidified Concentrate Distribution System potential electrical safety hazard may result in electric shock, arching
-
- Terminated Z-0821-2020
There is a potential for an uneven plastic encapsulation of the magnet ring during the molding process and partial axial displacement. This issue could cause uneven wear during use, cause exposure of the magnet to solution, and thereby result in corrosion and the presence of iron.
Timeline
- Cleared FDA 510(k) K120005
- Recall initiated FDA recalls Z-0821-2020
- Recall initiated FDA recalls Z-1739-2022
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- KPO
- Device class
- Class II
- Regulation
- 21 CFR Part 876.5820
- Advisory committee
- Gastroenterology, Urology
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The ACDS is a Dialysate Concentrate for Hemodialysis (Liquid or Powder) designed for automated storage and distribution of acidified concentrate in clinical settings. It ensures precise dosing and delivery of hemodialysis fluids by integrating storage tanks, pumps, and control units to maintain sterile and consistent concentrate distribution for renal therapy.
This system is supplied as a reusable, non-sterile medical device intended for use in hemodialysis facilities. It adheres to AAMI National Standards for hemodialysis and operates within FDA 510(k) clearance (K120005) under regulation 876.5820. The device is engineered for clinical environments, with components including acid concentrate tanks, pumps, and monitoring alerts for low-tank levels, ensuring reliable fluid management for renal treatment protocols.
Devices cleared under K120005
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| Acidified Concentrate Distribution and Storage (ACDS) System MD704262 | MD704262 | 00852456007092 | — | On the market |
Similar devices
Other devices filed under FDA product code KPO (Dialysate Concentrate For Hemodialysis (Liquid Or Powder)).
- BICART by Gambro Renal Products, Inc.
- ACIDIFIED COMPONENT CONCENTRATES FOR BICARBONATE DIALYSIS CONTAINING DI-ACETATE by Rockwell Medical Technologies, Inc.
- PRISMASATE DIALYSIS SOLUTIONS FOR CONTINUIUS RENAL REPLACEMENT THERAPY by Gambro Renal Products, Inc.
- ALTHIN MEDICAL AB ALTRACART II by Althin Medical AB
- FRESENIUS NATURALYTE SODIUM BICARBONATE LIQUID CONCENTRATE, MODEL 08-4000-LB by Fresenius Medical Care North America
- SOLCART B by B. Braun Medizintechnologie GmbH
- Citrasate Dry Acid Concentrate, Granuflo Dry Acid Concentrate by Fresenius Medical Care Renal Therapies Group, LLC
- Citric Complete Liquid Citric Acid Concentrate by NIPRO RENAL SOLUTIONS USA CORPORATION
- NxStage PureFlow Solution by NxStage Medical, Inc.
- ACCUSOL DIALYSIS SOLUTION by Baxter Healthcare Corp